Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
26 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Companies
Top Ten Companies //
Browse A - Z of companies
Merck KGaA
(Merck)
Merck
(Merck KGaA)
Pfizer
Roche
Novartis
GlaxoSmithKline
(GSK)
GSK
(GlaxoSmithKline)
Bristol-Myers Squibb
Lilly
Bayer
Browse the A - Z of Companies
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
J
J B Chemicals & Pharmaceuticals
Jain An Pharmaceuticals
Jamjoon Pharmacy
Jamp Pharma
Janssen
Janssen Biotech
Janssen Pharmaceutica
Janssen-Cilag
Japan Tobacco
Javelin
Jazz Pharmaceuticals
JB Chemicals & Pharmaceuticals
JCR Pharmaceuticals
Jenapharm
Jennerex
JHP Pharmaceuticals
Jiangsu Hengrui Medicine
Jiangsu NHWA
Jilin Boda
Johnson & Johnson
JSW Life Sciences
Jubilant
Julphar
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth